Literature DB >> 27701910

Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Juan Eduardo Megías-Vericat1,2, Pau Montesinos3, María José Herrero1,4, Federico Moscardó3, Virginia Bosó1,2, Luis Rojas1,5, David Martínez-Cuadrón3, David Hervás6, Blanca Boluda3, Ana García-Robles2, Rebeca Rodríguez-Veiga3, María Martín-Cerezuela2, José Cervera3, Luis Sendra4, Jaime Sanz3, Antonio Miguel4, Ignacio Lorenzo3, José Luis Poveda2, Miguel Ángel Sanz3, Salvador F Aliño1,4,7.   

Abstract

Anthracycline uptake could be affected by efflux pumps of the ABC family. The influence of 7 SNPs of ABC genes was evaluated in 225 adult de novo acute myeloid leukemia (AML) patients. After multivariate logistic regression there were no significant differences in complete remission, though induction death was associated to ABCB1 triple variant haplotype (p = .020). The ABCB1 triple variant haplotype was related to higher nephrotoxicity (p = .016), as well as this haplotype and the variant allele of ABCB1 rs1128503, rs2032582 to hepatotoxicity (p = .001; p = .049; p < .001). Furthermore, the variant allele of ABCC1 rs4148350 was related to severe hepatotoxicity (p = .044), and the variant allele of ABCG2 rs2231142 was associated to greater cardiac (p = .004) and lung toxicities (p = .038). Delayed time to neutropenia recovery was observed with ABCB1 rs2032582 variant (p = .047). This study shows the impact of ABC polymorphisms in AML chemotherapy safety. Further prospective studies with larger population are needed to validate these associations.

Entities:  

Keywords:  ABC; SNP; Transporter; acute myeloid leukemia; anthracyclines; efficacy; idarubicin; polymorphism; toxicity

Mesh:

Substances:

Year:  2016        PMID: 27701910     DOI: 10.1080/10428194.2016.1231405

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  13 in total

Review 1.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

2.  The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.

Authors:  Sung-Han Hsiao; Sabrina Lusvarghi; Yang-Hui Huang; Suresh V Ambudkar; Sheng-Chieh Hsu; Chung-Pu Wu
Journal:  Cancer Lett       Date:  2019-01-11       Impact factor: 8.679

3.  Immunorelated gene polymorphisms associated with acute myeloid leukemia.

Authors:  Q Liu; M Hua; S Yan; C Zhang; R Wang; X Yang; F Han; M Hou; D Ma
Journal:  Clin Exp Immunol       Date:  2020-06-02       Impact factor: 4.330

Review 4.  hiPSCs in cardio-oncology: deciphering the genomics.

Authors:  Emily A Pinheiro; K Ashley Fetterman; Paul W Burridge
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

5.  Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.

Authors:  Kateryna Petrykey; Aziz M Rezgui; Mathilde Le Guern; Patrick Beaulieu; Pascal St-Onge; Simon Drouin; Laurence Bertout; Fan Wang; Jessica L Baedke; Yutaka Yasui; Melissa M Hudson; Marie-Josée Raboisson; Caroline Laverdière; Daniel Sinnett; Gregor U Andelfinger; Maja Krajinovic
Journal:  Pharmacogenomics       Date:  2021-09-10       Impact factor: 2.638

6.  Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma.

Authors:  Marianna Avitabile; Vito Alessandro Lasorsa; Sueva Cantalupo; Antonella Cardinale; Flora Cimmino; Annalaura Montella; Dalila Capasso; Riccardo Haupt; Loredana Amoroso; Alberto Garaventa; Alessandro Quattrone; Maria Valeria Corrias; Achille Iolascon; Mario Capasso
Journal:  J Cell Mol Med       Date:  2020-02-27       Impact factor: 5.310

7.  Long-term cardiac-specific mortality among 44,292 acute myeloid leukemia patients treated with chemotherapy: a population-based analysis.

Authors:  Guangli Li; Zhijuan Zhou; Wencong Yang; Hao Yang; Xiuwu Fan; Yuelan Yin; Liyun Luo; Jinyou Zhang; Niujian Wu; Zibin Liang; Jianting Ke; Jian Chen
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

8.  Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group.

Authors:  Kelly D Getz; Lillian Sung; Bonnie Ky; Robert B Gerbing; Kasey J Leger; Allison Barz Leahy; Leah Sack; William G Woods; Todd Alonzo; Alan Gamis; Richard Aplenc
Journal:  J Clin Oncol       Date:  2018-10-31       Impact factor: 50.717

9.  Ethnogeographic and inter-individual variability of human ABC transporters.

Authors:  Qingyang Xiao; Yitian Zhou; Volker M Lauschke
Journal:  Hum Genet       Date:  2020-03-23       Impact factor: 4.132

Review 10.  Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia.

Authors:  Carmelo Gurnari; Simona Pagliuca; Valeria Visconte
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.